Morgan & Morgan Announces the Investigation of Thoratec Corp. - THOR

NEW YORK, July 22, 2015 /PRNewswire/ -- Morgan & Morgan announces that it is investigating the Board of Directors of Thoratec Corp. ("Thoratec" or the "Company") (THOR) for possible breaches of fiduciary duty and other violations of law in connection with the sale of the company to St. Jude Medical Inc. (STJ).

If you own shares of Thoratec and would like to learn more about the Thoratec shareholder investigation, you may contact Morgan & Morgan at 1(800) 732-5200 or email [email protected].

Under the terms of the proposed transaction, shareholders will receive $63.50 in cash for each share of Thoratec stock they own. The proposed transaction is valued at approximately $3.4 billion. The investigation relates to whether the proposal is fair to the public shareholders of Thoratec and whether Thoratec's Board breached its fiduciary duties in connection with the proposed sale.

About Morgan & Morgan

Morgan & Morgan is one of the nation's largest 200 law firms.  In addition to shareholder rights, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability.  All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."

Attorney advertising.  Prior results do not guarantee a similar outcome.

Contact: Morgan & Morgan Peter Safirstein, Esq. 28 West 44th Street Suite 2001 New York, NY  10036 1-800-732-5200 [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/morgan--morgan-announces-the-investigation-of-thoratec-corp--thor-300117361.html

SOURCE Morgan & Morgan